Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial.
about
Multiple versus one or more antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attackClopidogrel and Aspirin versus Aspirin Alone for Stroke Prevention: A Meta-AnalysisPotential role of aspirin in the prevention of aneurysmal subarachnoid hemorrhage.The challenge of stroke prevention with intracranial arterial stenosisTreatment and imaging of intracranial atherosclerotic stenosis: current perspectives and future directionsImpact of MCA stenosis on the early outcome in acute ischemic stroke patientsMicroembolic signals detected with transcranial doppler sonography differ between symptomatic and asymptomatic middle cerebral artery stenoses in Northeast China.Vascular imaging in stroke: comparative analysisAsymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): a prospective observational studyDifferent levels of blood pressure, different benefit from dual antiplatelet therapy in minor stroke or TIA patients.A systematic review and meta-analysis of published randomized controlled trials of combination of clopidogrel and aspirin in transient ischemic attack or minor strokeSymptomatic Carotid Artery Stenosis: Surgery, Stenting, or Medical Therapy?Dual antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack: pros and consEfficacy and safety of adding clopidogrel to aspirin on stroke prevention among high vascular risk patients: a meta-analysis of randomized controlled trials.Infarct patterns, collaterals and likely causative mechanisms of stroke in symptomatic intracranial atherosclerosis.Research on intracranial atherosclerosis from the East and west: why are the results different?Dual antiplatelet therapy in secondary prevention of ischemic stroke: a ghost from the past or a new frontier?Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort studyThe efficacy and adverse reaction of bleeding of clopidogrel plus aspirin as compared to aspirin alone after stroke or TIA: a systematic review.Proximal arterial occlusion in acute ischemic stroke with low NIHSS scores should not be considered as mild stroke.Low-molecular-weight heparin or dual antiplatelet therapy is more effective than aspirin alone in preventing early neurological deterioration and improving the 6-month outcome in ischemic stroke patients.Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.Intracranial atherosclerotic disease.Prediction factors of recurrent ischemic events in one year after minor stroke.Aspirin resistance in the acute stages of acute ischemic stroke is associated with the development of new ischemic lesions.Sample size calculations for skewed distributions.Wingspan Stenting for Severe Symptomatic Intracranial Atherosclerotic Stenosis in 433 Patients Treated at a Single Medical CenterDual antiplatelet therapy after stroke or transient ischaemic attack - how long to treat? The duration of aspirin plus clopidogrel in stroke or transient ischaemic attack: a systematic review and meta-analysis.Antiplatelet therapy as a modulator of stroke aetiology: a meta-analysis.Treatment of vertebral artery origin stenosis with a Pharos stent device: a single center experience.Efficacy and safety of short-term dual- versus mono-antiplatelet therapy in patients with ischemic stroke or TIA: a meta-analysis of 10 randomized controlled trials.Dual antiplatelet therapy in stroke and ICAS: Subgroup analysis of CHANCEStroke radiology and distinguishing characteristics of intracranial atherosclerotic disease in native South Asian Pakistanis.Stenting versus aggressive medical therapy for intracranial arterial stenosis.A Comparison of Stent Implant versus Medical Treatment for Severe Symptomatic Intracranial Stenosis: A Controlled Clinical TrialTranscranial Doppler: Techniques and advanced applications: Part 2Pretreatment with a combination of ligustrazine and berberine improves cardiac function in rats with coronary microembolizationDepression in patients with chronic hepatitis B and cirrhosis is closely associated with the severity of liver cirrhosis.Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack.Intensive risk factor control in stroke prevention.
P2860
Q24201386-E623FE4B-0A91-4E05-BEE0-81A7AEDEB229Q26798213-C93CB7AC-192E-483F-B1C8-42AE54ED33D8Q26998381-59A512B4-68C0-42BB-937E-7C0FC3ECB965Q27010215-2B5E0546-C31D-48BC-A4BB-9D345AAFB472Q28066089-866A25D6-5A8D-435B-BA4B-4343FAC029BCQ30357356-42F94473-1105-449A-BCD2-112D55F0DAD7Q30442928-27680E16-DF8E-40E9-9B72-83832FCAA422Q30466240-317100E7-94AA-4DF7-B761-12CA65B3E1F5Q30480493-19CA31E3-0E7B-425A-9324-8C9BAD214650Q33818924-5D3FCAFB-06F4-4FF3-A02E-78B1B2E5FA51Q33846950-47322474-E537-404E-9BD8-146077033D44Q33871078-DCDB3413-468A-4FD3-A096-5D6AC5667CF0Q33911647-15CDC4C4-1B0C-4493-8874-04EC18B84781Q34028223-8C1929D7-BF22-4015-B14E-CC1E5AFA1ECDQ34076214-A38B8F49-DF5D-47EA-AC3A-31929E226E17Q34357545-6A453FA5-19DC-4E47-81E2-AB7C4F1AD341Q34479105-DD41714E-38A3-4A25-9BF6-FE28A92E04EFQ34635205-31C27A0B-D855-4CDE-BEC3-492DE6DA5AA4Q34804730-57C3B30C-8F26-4B30-820F-92B829915E42Q34970483-5F67BC2E-03D5-4387-842A-D2E98ECF7907Q34996542-430E1D57-659A-445D-AAC9-F539DF45E789Q35105098-7221B5B1-475D-428F-AD22-C5DA29D70191Q35109949-CB39D50E-6CB2-4536-9017-73A84B7AD796Q35181883-09F188C8-DB9D-4D94-B9C0-A93C27BF73E4Q35301978-198335C7-8FEE-496F-B976-D577A28B39FDQ35580527-32C8ADFE-B3EB-4F80-B2D3-276A3C968A54Q35793878-9640C171-9C75-4862-8F32-2193C31CDDFAQ35972254-CE609284-3D0E-44E8-A120-3446ED322F31Q36072444-2E5BC268-87D5-481F-828F-C8D9BE9E8CD1Q36092848-9A357C9F-EE10-468E-AB78-8C7CC49438EAQ36107806-244980F5-F07B-42D2-AB20-809D5D3F45FBQ36156689-C960E99B-77EB-4B68-8807-2661BCC5FC5EQ36494736-A6528A34-4865-4441-BBA3-94452A65FCB2Q36555224-8C3C0377-FCB7-4133-AE5A-BA2C9C4B64ABQ36596918-2C13039E-E1FF-4EAD-83E9-050CDE8850BAQ36662843-534D5289-E450-4ABF-8C85-57C0BD711A94Q36765102-B5A671C9-CA52-4FD5-B0B1-ADBE5FA1EF66Q37001709-3A2FB19F-4164-4D35-AE19-EB4042B5DA6DQ37090842-084F35FD-B6FE-4DF0-B02F-EEB1C363B1F0Q37215333-BC47D34A-013C-405C-9B57-193278453E22
P2860
Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Clopidogrel plus aspirin versu ...... label, blinded-endpoint trial.
@en
Clopidogrel plus aspirin versu ...... label, blinded-endpoint trial.
@nl
type
label
Clopidogrel plus aspirin versu ...... label, blinded-endpoint trial.
@en
Clopidogrel plus aspirin versu ...... label, blinded-endpoint trial.
@nl
prefLabel
Clopidogrel plus aspirin versu ...... label, blinded-endpoint trial.
@en
Clopidogrel plus aspirin versu ...... label, blinded-endpoint trial.
@nl
P2093
P921
P1433
P1476
Clopidogrel plus aspirin versu ...... label, blinded-endpoint trial.
@en
P2093
Angeline Koh
CLAIR study investigators
Disya Ratanakorn
Hugh S Markus
Hui Meng Chang
Jianhui Fu
Ka Sing Lawrence Wong
Kay Sin Tan
Nijasri C Suwanwela
Pavithra Chollate
P304
P356
10.1016/S1474-4422(10)70060-0
P577
2010-03-22T00:00:00Z